Arcadia Biosciences expecting dramatic growth in 2020 after posting 4Q earnings

Proactive Investors

View Source

Arcadia Biosciences posted fourth-quarter and full-year results after the bell Wednesday revealing plans for dramatic growth in 2020. CEO Matt Plavan says the company successfully laid the foundations for its research program in three geographic areas and established a vertically integrated supply chain for its hemp seed. Plavan adds the company will expect to grow its 2020 revenues 10-15 fold than 2019 revenues.